Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004951442 | SCV005544474 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-07-11 | criteria provided, single submitter | clinical testing | The p.V709D variant (also known as c.2126T>A), located in coding exon 8 of the BLM gene, results from a T to A substitution at nucleotide position 2126. The valine at codon 709 is replaced by aspartic acid, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |
Natera, |
RCV001279094 | SCV001466157 | uncertain significance | Bloom syndrome | 2020-09-04 | no assertion criteria provided | clinical testing |